Testosterone gets marketed like a “men’s hormone,” but in real physiology it’s more like a shared neurotransmitter-adjacent signal—one that nudges drive, motivation, mood, libido, and confidence in both men and women. Not as a magic wand. More like a volume knob: when it’s too low, the world can feel dimmer; when it’s pushed too high, it can distort.
The overlap: why men and women both feel it
Testosterone influences sexual function and wellbeing, but it also threads through energy, initiative, and self-perceived vitality—often described clinically as “motivation,” “mood,” and “sense of self.” In women, the best evidence-based use is quite specific: postmenopausal hypoactive sexual desire disorder (HSDD), where physiologic dosing shows a moderate benefit for sexual desire and related domains.
That specificity matters, because in the social-media era testosterone is sometimes sold as a cure-all. The evidence is not a blank cheque.
A brief, fascinating history of TRT
Modern testosterone therapy began once testosterone was isolated and synthesized in the 1930s, which turned a biological mystery into a prescribable molecule.
From there, the story became pharmaceutical engineering: how to deliver a hormone that the body normally releases in pulses, without melting the liver, spiking levels, or turning physiology into a rollercoaster.
Men vs women: the fertility paradox
In men, testosterone can act like contraception
Here’s the key concept: sperm production depends on the brain–testis conversation.
When a man uses exogenous testosterone, the hypothalamus and pituitary sense “enough androgen” and turn down LH/FSH signals. That reduces intratesticular testosterone (inside the testes), which is crucial for spermatogenesis—so sperm counts can fall dramatically, even to azoospermia.
That’s why major guidelines recommend against TRT in men planning fertility in the near term.
In women, therapeutic testosterone usually doesn’t “switch off” fertility the same way
This is the interesting part. The evidence-based use in women is generally low-dose, physiologic-range testosterone (typically transdermal) aimed at restoring levels closer to normal premenopausal ranges—often in postmenopausal women where ovulation is no longer the central issue.
So why the difference?
- Dose and target range: Women’s therapy is designed to stay within physiologic female ranges, not male levels.
- Different “bottleneck”: Male fertility relies heavily on high intratesticular testosterone driven by LH/FSH. Women’s ovulation is regulated differently; high androgen exposure can disrupt cycles, but physiologic, carefully monitored dosing for HSDD typically isn’t used as an ovulation-suppressing tool. (Important: testosterone is not used as a fertility treatment in women, and pregnancy is generally a no-go while using it—this is clinician territory.)
Testosterone across the lifespan: children, puberty, peaks
In childhood, testosterone is generally low. In boys it rises through puberty and, in population models, peaks around late adolescence (about age 19), then gradually declines into adulthood.
In girls, testosterone also rises at puberty (much less dramatically), with a notable contribution from both ovaries and adrenal glands during pubertal development.
Large modelling work suggests in females circulating testosterone peaks in late adolescence and then declines gradually through early adulthood.
That pubertal rise is one reason adolescence can feel like a motivational and emotional amplifier: hormones don’t create personality, but they can turn up the intensity.
Safety and “why it’s not a simple pill”
Why not just swallow testosterone?
Unmodified testosterone is rapidly inactivated by first-pass liver metabolism, which historically made oral delivery ineffective.
Early “workarounds” (like 17-α alkylated oral androgens) improved oral bioavailability but came with meaningful liver toxicity risks—a major reason modern therapy moved toward non-oral routes.
There are newer oral options (testosterone undecanoate formulations) designed to avoid first-pass metabolism via lymphatic absorption, but they’re not the same as “simple testosterone pills,” and they still require careful monitoring and prescribing context.
Common modes of administration
- Transdermal gels/creams (steady-ish delivery; risk of transfer to others if not careful)
- Injections (can create peaks/troughs depending on formulation)
- Patches (less common in some markets)
- Pellets (long-acting but harder to adjust; higher risk of drifting into supraphysiologic levels)
For women, consensus statements emphasize physiologic dosing and monitoring, with short-term trials showing no serious adverse events at appropriate doses, though long-term data are more limited.
For men, guidelines stress structured monitoring (symptoms, testosterone levels, hematocrit, and prostate-risk assessment in appropriate age groups) and avoiding TRT in certain situations (including fertility plans).
Lifestyle ways to support testosterone (the boring classics that work)
If hormones are the orchestra, lifestyle is the acoustics.
Evidence-leaning, clinician-approved basics:
- Resistance training / heavy lifting: tends to cause acute rises in testosterone after sessions in men; long-term effects vary, but strength training supports body composition and metabolic health.
- Healthy weight: excess adiposity is linked to lower testosterone via multiple mechanisms (including altered hormone binding and aromatization).
- Sleep and stress: poor sleep and chronic stress can blunt hormonal rhythms.
- Limit heavy alcohol and address untreated sleep apnea (important in clinical TRT decisions).
Supplements and “alternatives” (use caution, but here’s the map)
Clomiphene (Clomid) in men
Clomiphene is a SERM that can increase endogenous testosterone by changing estrogen feedback at the hypothalamus/pituitary—often used off-label in men where fertility preservation matters. Evidence shows it can raise testosterone and may support sperm parameters in some contexts.
This is prescription territory and should be guided by a clinician, especially if fertility is a goal.
DHEA
Meta-analyses suggest DHEA supplementation can increase testosterone, with the rise often more pronounced in women than men, but benefits and long-term safety are not universal and depend on context (age, dose, baseline levels, and hormone-sensitive risks).
“Testosterone boosters”
Many over-the-counter boosters have mixed evidence and quality-control issues. If someone chooses supplements, third-party testing and medical review matter—especially if there are mood conditions, endocrine disorders, or other medications in the picture.
A grounded conclusion (with a bit of lyricism)
Testosterone therapy is most beautiful when it’s humble—replacement, not reinvention. Done well, it’s not about becoming someone else; it’s about restoring a signal your body used to send clearly. Done badly—overprescribed, overdosed, treated like a personality upgrade—it can cost fertility, stability, and trust.
The goal is not more testosterone.
The goal is enough.
